Results 101 to 110 of about 4,313 (158)

Biologic Switching in Patients with Severe Asthma: Effects on Exacerbations, Corticosteroid Use and Lung Function. [PDF]

J Clin Med
Dindar Çelik F, Aksu K.
europepmc   +1 more source

Case Report: Benralizumab combined with a steroid-sparing strategy in a case of severe eosinophilic granulomatosis with polyangiitis. [PDF]

Front Immunol
Zhou N, Fang C, Feng M, Dong C.
europepmc   +1 more source

Therapeutic Efficacy of Anti-Interleukin-5 Monoclonal Antibodies in Kimura Disease: A Systematic Review. [PDF]

Cureus
Olizarowicz S, Mierzejewski M, Majewski M, Szczepanska P.   +3 more
europepmc   +1 more source

Pediatric spontaneous-reporting patterns for biologics approved or used for asthma: Analysis of the FDA adverse event reporting system. [PDF]

Pediatr Allergy Immunol
Zhang Y, Liu Y, Chen L, Chen Y, Zheng X.
europepmc   +1 more source

Biological functions and clinical efficacy of IL-5/IL-5Rα-targeted therapies across eosinophilia-associated diseases. [PDF]

Front Immunol
Lübke J, Reiter A, Schwaab J.
europepmc   +1 more source

New perspectives in the treatment of chronic eosinophilic pneumonia in the era of targeted therapies. [PDF]

Front Immunol
Scelfo C, Simonazzi A, Ruggiero P, Pellegrino MR, Facciolongo N.   +4 more
europepmc   +1 more source

The Use of Biological Therapies in the Treatment of Chronic Rhinosinusitis with Nasal Polyps: Current State of Knowledge. [PDF]

J Clin Med
Wrona J, Krupa Z, Zawadzka M, Rydzek J, Muzyka A, Dorobisz K, Pazdro-Zastawny K.   +6 more
europepmc   +1 more source

Hypereosinophilia With Pseudomonas aeruginosa Infection in Patients With Asthma on Anti-Inteleurkin-5 Biologics. [PDF]

Chest
Rivard R, Mailhot-Larouche S, Borg C, Pujan P, Klein M, Lachapelle P, Couillard S.   +6 more
europepmc   +1 more source

Biologic therapies targeting type 2 inflammation in NSAID-exacerbated respiratory disease. [PDF]

Front Immunol
Szatkowski P, Çelik GE, Mejza F, Mastalerz L.   +3 more
europepmc   +1 more source

IL-5/IL-5R blockade enables safe non-steroidal anti-inflammatory agent reintroduction in non-steroidal anti-inflammatory exacerbated respiratory disease. [PDF]

Front Immunol
Korkmaz P, Kahveci N, Demir S, Yegit OO, Unal D, Igde MH, Sezgin ME, Aslan AF, Erden B, Bolek L, Atasever MD, Guzel SE, Kamacı ŞÇ, Kaya E, Gelincik A.   +14 more
europepmc   +1 more source